* BELLUS Health Inc BLU.TO reported a quarterly adjusted
loss
of 20 cents per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 16 cents per share.
* Revenue held steady 0% to $4.00 thousand from a year ago;
analysts expected $3.50 thousand.
* BELLUS Health Inc's reported EPS for the quarter was a
loss
of 20 cents.
* The mean earnings estimate of analysts had risen by
about 10% in
the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* BELLUS Health Inc shares had fallen by 17.4% this
quarter and
gained 18.5% so far this year.
* The company reported a quarterly loss of $24.71 million.
* Wall Street's median 12-month price target for BELLUS
Health Inc
is C$22.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
15 at 12:00 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.16 -0.20 Missed
Jun. 30 2022 -0.17 -0.18 Missed
Mar. 31 2022 -0.20 -0.13 Beat
Dec. 31 2021 -0.22 -0.18 Beat